C. Supplements/AddendaArt. 12
Supplements Supplements may be published either in the final term sheet for the issue in question, or as an addendum to the issuance programme. Art. 13
Application and deadlinesChanges and additions to information contained in the registered issuance programme about the issuer and about those parties involved in the structure of the ETPs (incl. changes to the securities provided for under the registered issuance programme) which are made during the 12-month validity period must be submitted to the Regulatory Board in the form of a supplementary document to the registered issuance programme (supplement/addendum) for review and approval, together with an application. Art. 14
Decision1 The decision of the Regulatory Board will generally be made within 20 exchange days of receipt of the complete application. The issuer will be notified in writing. 2 The supplements or addenda in question do not become part of the issuance programme until they have been approved by the Regulatory Board. 3 Once the Regulatory Board has given its approval, in addition to the normal reference to the registered issuance programme, the listing prospectus must also contain a clear reference to the supplement/addendum in connection with the securities to be listed. 4 The registered issuance programme, together with the approved supplement/addendum, must be supplied to investors upon request. Art. 15
Additions as a result of ongoing financial reporting and course of business1 Where the information contained in the registered issuance programme about the issuer is updated as a result of its financial reporting and the course of its business (e.g. interim financial statements, ad hoc reports), the issuer is subject only to a duty to inform. 2 If it has been amended, the issuer must provide the Regulatory Board with the corresponding issuance programme in electronic form. The Regulatory Board will not take any new decisions in this regard. See also:
| 
